The initial public offering (IPO) market is remaining red hot for the week ahead, with 14 traditional IPOs aiming to raise nearly $6.79 billion in their debut. The week hosts a diverse grouping of companies, including web developers, industry pureplays, electronic producers, biotechs, and digital marketers.
Diversey Holdings, Ltd. (DSEY ) plans to raise over $1.11 billion from more than 46 million shares priced between $18 to $21 each. The cleaning products maker is a global pure play provider of cleaning and hygiene products for institutional and industrial end-users such as food service providers, lodging establishments, food and beverage manufacturing and processing plants, building service contractors, building managers and property owners, retail outlets, schools and health-care facilities in 175 counties. Diversey's competitors include 3M (MMM ), Procter & Gamble (PG ), Clorox (CLX ) and Kimberly-Clark (KMB ).
DigitalOcean Holdings, Inc. (DOCN ) plans to raise about $892 million from 16.5 million shares priced in the range of $44 to $47 each. The web development platform provides the capabilities of cloud infrastructure and services to individual developers, start-ups and small-to-midsized businesses, offering simpler cloud services than the scable ones offered by tech giants like AWS (AMZN ) and Google Cloud (GOOGL ).
Leonardo DRS, Inc. (DRS ) plans to raise over $807 million from 31.9 million shares priced between $20 to $22 each. As the spin-off of Italian defense group Leonardo, the company provides defense products and technologies used across land, air, sea, space, and cyber domains. Top competitors include L3Harris Technologies (LHX ) and Raytheon (RTX ).
Zhihu Inc. (ZH ) plans to offer over $727 million from 55 million shares priced between $9.50 to $11.50 each. The Chinese internet platform offers the largest 'question and answer' online community and one of the top five comprehensive online content communities in China.
Alignment Healthcare, Inc. (ALHC ) plans to raise over $594 million from 27.2 million shares priced in the range of $17 to $19 each. The provider of customized Medicare Advantage plans operating in 22 markets across three U.S. states.
ACV Auctions Inc. (ACVA ) plans to raise roughly $419 million from more than 16.5 million shares priced between $20 to $22 each. The wholesale car auction platform helps facilitate transactions between dealers and commercial partners.
Vizio Holding Corp. (VZIO ) plans to raise nearly $400 million from over 15 million shares priced between $21 to $23 each. The company offers a portfolio of Smart TVs and sound bars, with competitors including Samsung, Sony (SNE ), and LG Electronics.
Cricut, Inc. (CRCT ) plans to raise over $387 million from more than 15.3 million shares priced between $20 to $22 each. The company offers connected machines, design apps and accessories and materials to allow users to make personalized crafts.
Olink Holding AB (OLK ) plans to raise over $365 million from more than 17.6 million shares priced between $16 to $18 each. The Swedish proteomics platform offered a portfolio of protein biomarker analysis products, based on proprietary Proximity Extension Assay technology.
SEMrush Holdings, Inc. (SEMR ) plans to raise over $309 million from 16.8 million shares priced between $14 to $16 each. The digital marketing management platform enables companies to identify and reach the right audience for their content through SEO research tools.
Design Therapeutics, Inc. (DSGN ) plans to raise over $276 million from 12 million shares priced between $18 to $20 each. The preclinical biotech plans to evaluate its lead candidate in clinical trials with Friedreich ataxia patients in the first half of 2022.
ThredUp Inc. (TDUP ) plans to raise $193 million from 12 million shares priced between $12 to $14 each. The secondhand apparel platform had 1.24 million active buyers and 428,000 active sellers as of Dec. 31, 2020. The company's top rivals include The RealReal (REAL ) and Poshmark (POSH ).
Edgewise Therapeutics, Inc. (EWTX ) plans to raise $184 million from 10 million shares priced between $14 to $16 each. The rare-disease-focused biotech's lead candidate is currenting in a Phase 1 trial for Duchenne muscular dystrophy, Becker muscular dystrophy, and Limb-girdle muscular dystrophy.
LAVA Therapeutics BV (LVTX ) plans to raise over $123 million from 6.7 million shares priced between $14 to $16 each. The Dutch oncology-focused biotech expects to begin enrollment for a Phase 1/2a clinical trial for its lead candidate in the first half ot the year.
